Related Experiment Video
Updated: Jun 30, 2026
07:13
Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Small, non-peptide C5a receptor antagonists: part 1
Julian Blagg1, Charles Mowbray, David C Pryde
1Department of Discovery Chemistry, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK.
Bioorganic & Medicinal Chemistry Letters
|September 24, 2008
Summary
Researchers optimized amides to create potent C5a receptor antagonists. These compounds show improved binding and functional activity, with potential therapeutic applications.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- The complement component 5a (C5a) receptor plays a crucial role in inflammatory and immune responses.
- Dysregulation of the C5a receptor is implicated in various diseases, making it a therapeutic target.
Purpose of the Study:
- To optimize a series of amide compounds for enhanced C5a receptor binding.
- To improve the functional activity and physicochemical properties of novel C5a receptor antagonists.
Main Methods:
- High-throughput screening (HTS) was employed to identify initial hit compounds.
- Structure-activity relationship (SAR) studies were conducted to optimize lead compounds.
- In vitro assays were used to assess C5a receptor binding affinity (IC50) and functional activity.
Main Results:
- An initial hit compound (1) with moderate C5a receptor binding affinity (IC50 = 1 microM) was identified.
- Through iterative optimization, highly potent C5a receptor antagonists were developed, exemplified by compound 14 (IC50 = 5 nM).
- Optimized compounds demonstrated significant improvements in both binding affinity and functional antagonism.
Conclusions:
- The study successfully identified and optimized a series of amide-based C5a receptor antagonists.
- These potent antagonists represent promising candidates for further development in treating C5a receptor-mediated inflammatory conditions.
Related Concept Videos
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:30Adrenergic Agonists: Direct-Acting Agents
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...